Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aditya Raghunathan

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Journal of Neuropathology and Experimental Neurology|April 25, 2025
EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?David J Cook, Paul A Decker, Jayson J Hardcastle, et al.
Nature Communications|January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trialEvanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2024
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patientsSurendra Dasari, Michael R McCarthy, Antonina A Wojcik, et al.
Human Pathology|December 25, 2023
Next generation sequencing-based identification of fusion-driven renal neoplasia: A single institution experienceBurak Tekin, Christopher D Hofich, Beth A Pitel, et al.
Human Pathology|May 17, 2025
Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistryRumeal D Whaley, Daniel R Sill, Burak Tekin, et al.
Mayo Clinic Proceedings|February 13, 2026
Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency)Michael McCarthy, Antonina A Wojcik, Emily G Barr Fritcher, et al.
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Cancer Cell|September 3, 2013
Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastomaKrishna P L Bhat, Veerakumar Balasubramaniyan, Brian Vaillant, et al.
Neuro-Oncology|December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment StrategiesAniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Journal of Neuropathology and Experimental Neurology|April 25, 2025
EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?David J Cook, Paul A Decker, Jayson J Hardcastle, et al.
Nature Communications|January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trialEvanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2024
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patientsSurendra Dasari, Michael R McCarthy, Antonina A Wojcik, et al.
Human Pathology|December 25, 2023
Next generation sequencing-based identification of fusion-driven renal neoplasia: A single institution experienceBurak Tekin, Christopher D Hofich, Beth A Pitel, et al.
Human Pathology|May 17, 2025
Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistryRumeal D Whaley, Daniel R Sill, Burak Tekin, et al.
Mayo Clinic Proceedings|February 13, 2026
Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency)Michael McCarthy, Antonina A Wojcik, Emily G Barr Fritcher, et al.
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Cancer Cell|September 3, 2013
Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastomaKrishna P L Bhat, Veerakumar Balasubramaniyan, Brian Vaillant, et al.
Neuro-Oncology|December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment StrategiesAniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 14